Monitor for any future conversion to a 13D filing or additional stake increases, which could signal a shift from passive to activist intent. The large increase in a micro-cap stock warrants attention.
KPTI drugs
KPTI drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $0.0260entry
- T+1 · 4d ago −3.85%α −3.48% · $0.0250
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Adage Capital Management filed an amended Schedule 13G disclosing a beneficial ownership of 2,013,106 shares (8.87%) of Karyopharm Therapeutics as of September 30, 2026, up from 203,129 shares (0.9%) in the prior filing three days ago. This is a large increase in a passive stake, but given the company's tiny $1M market cap and the passive nature of the filing, the impact is neutral.
Key Financial Metrics
Key Facts
- Adage Capital Management disclosed beneficial ownership of 2,013,106 shares (8.87%) of Karyopharm Therapeutics as of September 30, 2026.
- This is an increase from 203,129 shares (0.9%) disclosed in the prior SC 13G/A filed November 9, 2026.
- The stake includes 15,414 shares issuable upon exercise of warrants.
- The percentage is based on 22,681,460 shares outstanding as of August 6, 2026.
- The filing is a passive investor update under Rule 13d-1(b); no activist intent is indicated.
Financial Impact
Stake increased by approximately 1,809,977 shares; value at snapshot market cap of $1M is approximately $88,500.
Risk Factors
- Passive filing; no activist intent stated, but a large stake increase could precede future engagement.
- Company has a very small market cap ($1M), making it highly volatile and susceptible to ownership changes.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000919574-26-007570 |
| Document: 0000919574-26-007570-index.html | 0000919574-26-007570 |
| Document: 0000919574-26-007570.txt | 0000919574-26-007570 |
Track record
30 reports on KPTI
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +97.24% at T+60 after the Aug 13, 2026 report. 13 of 14 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.0102 Now $0.0290 +184.31% settles Feb 12
- Nov 13, 20263d ago NT 10-Q Bearish 7/10 Entry $0.0102 Now $0.0290 −184.31% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Viewing Entry $0.0260 Now $0.0290 +11.54% settles Feb 10
- Nov 9, 20267d ago SC 13G/A Neutral 2/10 Entry $0.0400 Now $0.0290 −27.50% settles Feb 5
- Nov 5, 202611d ago 8-K Bearish 8/10 Entry $0.0601 Now $0.0290 +51.75% settles Feb 3
- Nov 2, 202614d ago 8-K Bearish 10/10 Entry $0.0883 Now $0.0290 +67.16% settles Feb 1
- Nov 2, 202614d ago 8-K Bearish 7/10 Entry $0.1120 Now $0.0290 +74.11% settles Jan 29
- Oct 28, 202619d ago SC 13G/A Bearish 5/10 Entry $0.8798 Now $0.0290 +96.70% settles Jan 27
- Oct 22, 202625d ago 8-K Bearish 6/10 Entry $0.5175 Now $0.0290 +94.40% settles Jan 21
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $0.3150 Now $0.0290 −90.79% settles Jan 11
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers